All Topics
All Topics
Technology
Technology
Design
Design
Programming
Programming
Science
Science
News
News
Gaming
Gaming
Entertainment
Entertainment
Business
Business
Finance
Finance
Sports
Sports
Health
Health
Food
Food
Travel
Travel
Art
Art
Music
Music
Books
Books
Education
Education
Politics
Politics
Personal
Personal
No algorithm. No AI slop. No ads. Just RSS. Pro-human. Indie writers. Real journalism. Open web. Chronological. Hand toasted.

FDA Launches Safety Review of Abortion Drug Mifepristone; Trans Youth Sue to Shield Health Records

By

Rewire News Group Staff

4h ago· 3 min readenNews

Summary

The article reports on three major abortion-related developments: (1) The FDA has initiated a safety review of mifepristone, an abortion medication, amid ongoing political and legal battles over abortion access; (2) Transgender youth in New York have filed a lawsuit to protect their health records from a Department of Justice investigation; and (3) A Nevada court has temporarily blocked a law requiring parental consent or court orders for minors seeking abortions. The piece is a weekly roundup from Rewire News Group covering abortion news across the United States.

Key quotes

· 3 pulled
Each week, Rewire News Group editors scour headlines nationwide
Plus, trans kids in New York sue to protect their health records from DOJ probe and Nevada minors can get an abortion without parental consent or a court order—for now.
RNG stays on top of abortion news so you don't have to.
Snippet from the RSS feed
Plus, trans kids in New York sue to protect their health records from DOJ probe and Nevada minors can get an abortion without parental consent or a court order—for now.

You might also wanna read